[1]肖蓉蓉,孙建斌.粪便Hp抗原检测对慢性萎缩性胃炎辅助诊断及病情评估的价值[J].现代检验医学杂志,2019,34(05):64-67.[doi:10.3969/j.issn.1671-7414.2019.05.016]
　XIAO Rong-rong,SUN Jian-bin.Value of Fecal Hp Antigen Detection in Diagnosis and Assessment of Chronic Atrophic Gastritis[J].Journal of Modern Laboratory Medicine,2019,34(05):64-67.[doi:10.3969/j.issn.1671-7414.2019.05.016]
点击复制

粪便Hp抗原检测对慢性萎缩性胃炎辅助诊断及病情评估的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年05期
页码:
64-67
栏目:
论著
出版日期:
2019-10-29

文章信息/Info

Title:
Value of Fecal Hp Antigen Detection in Diagnosis and Assessment of Chronic Atrophic Gastritis
文章编号:
1671-7414(2019)05-064-04
作者:
肖蓉蓉; 孙建斌
(武汉市第三医院检验科,武汉 430000)
Author(s):
XIAO Rong-rong; SUN Jian-bin
(Department of Clinical Laboratory,Wuhan Third Hospital,Wuhan 430000,China)
关键词:
慢性萎缩性胃炎;  粪便Hp抗原;  胃肠激素;  炎症因子
分类号:
R573.32; R446.13
DOI:
10.3969/j.issn.1671-7414.2019.05.016
文献标志码:
A
摘要:
目的 探讨粪便Hp抗原(HpSA)检测对慢性萎缩性胃炎(CAG)辅助诊断及病情评估的价值。方法 选取2015年9月～2018年1月收治的CAG患者118例作为CAG组,同期进行常规胃镜体检并确诊健康的志愿者100例作为正常对照组,对两组研究对象粪便标本的HpSA阳性情况进行判定,并对比其胃肠激素[胃蛋白酶原Ⅰ(PGⅠ),胃蛋白酶原Ⅱ(PGⅡ)及胃泌素-17(G-17)],炎症因子[白介素-8(IL-8),白介素-11(IL-11),白介素-32(IL-32)及肿瘤坏死因子α(TNF-α)]含量的差异。结果 CAG组患者粪便标本中HpSA阳性率显著高于正常对照组(82.20% vs8.0%),差异有统计学意义(χ2=119.376,P=0.000),CAG组患者血清中PGⅠ的含量低于正常对照组(98.37±13.45 vs 55.19±7.43 ng/ml),G-17水平高于正常对照组(163.05±22.74 vs 113.29±17.15 ng/L),血清中炎症因子IL-8,IL-11,IL-32和TNF-α的含量高于正常对照组(12.01±1.85 vs 9.73±1.64 pg/ml,16.19±1.84 vs 13.05±1.76 pg/ml,24.11±3.76 vs 20.73±3.41 pg/ml,7.61±0.89 vs 6.58±0.84 pg/ml),差异均有统计学意义(t=6.902～29.915,均P=0.000),其中CAG组HpSA阳性患者上述指标含量变化程度大于HpSA阴性患者,差异有统计学意义(t=19.134,11.826,9.163,10.426,6.371,5.571,均P=0.000)。结论 CAG患者的粪便HpSA阳性率显著高于胃黏膜正常者,而粪便HpSA阳性的CAG患者胃肠激素分泌紊乱与自身炎症反应均较为严重。
Abstract:
Objective To investigate the value of fecal Hpantigen(HpSA)detection in diagnosis and assessment of chronic atrophic gastritis(CAG).Methods 118 cases of CAG patients in Wuhan ThirdHospital from September 2015 to January 2018 were treated as CAG group,100 cases of normal gastroscopy and healthy volunteers in the Third Hospital of Wuhan atthe same time were chosen as normal control group.The HpSA positive conditionsof two groups were determined,gastrointestinal hormones [pepsinogen I(PG I),pepsinogen II(PG II)and gastrin-17(G-17)],inflammatory factors [interleukins-8(IL-8),interleukin-11(IL-11),interleukin-32(IL-32),tumor necrosis factor alpha(TNF-alpha)] between two groups were compared.Results Positive rate of HpSA in stool specimens in CAG group was significantly higher than that in normal control group(82.20% vs 8.0%)the difference was statistically signficant(χ2=119.376,P=0.000).Serum contentof PG I in CAG group was lower than that in normal control group(98.37±13.45 vs 55.19±7.43 ng/ml),G-17 was higher than that in normal control group(163.05±22.74 vs 113.29±17.15 ng/L),serum contents of inflammatory factorssuch as IL-8,IL-11,IL-32 and TNF-α were higher than those in normal control group(12.01±1.85 vs 9.73±1.64 pg/ml,16.19±1.84 vs 13.05±1.76 pg/ml,24.11±3.76 vs 20.73±3.41 pg/ml,7.61±0.89 vs 6.58±0.84 pg/ml),the difference was statistically signficant(t=6.902～29.915,all P=0.000),and changes of above indexes in HpSA positive patients of CAG group were greater than those in HpSA negative patients,the difference was statistically significant(t=19.134,11.826,9.163,10.426,6.371 and 5.571,all P=0.000).Conclusion Positive rate of HpSA in stool of CAG patients was significantly higher than that in normal gastric mucosa people.The gastrointestinal hormone secretion disorder was aggravated and systemic inflammatory response is more serious in CAG patients with HpSA positive stool.

参考文献/References:

[1] YAMADA S,TOMATSURI N,KAWAKAMI T,et al.Helicobacter pylorieradication therapy ameliorates latent digestive symptoms in chronic atrophic gastritis[J].Digestion,2018,97(4):333-339. [2] 杨建华,王炳华,林勇.血清胃蛋白酶原和胃泌素-17对萎缩性胃炎及胃癌患者诊断价值[J].现代检验医学杂志,2016,31(3):51-54. YANG Jianhua,WANG Binghua,LIN Yong.Clinical value of serum pepsinogen and gastrin-17 levels in patients with atrophic gastritis and gastric cancer[J].Journal of Modern Laboratory Medicine,2016,31(3):51-54. [3] 蔡惠美,林晖,欧希龙,等.联合胃蛋白酶原,胃泌素,粪便Hp抗原检测对萎缩性胃炎和胃癌的诊断价值[J].东南大学学报(医学版),2018,37(3):406-410. CAI Huimei,LIN Hui,OU Xilong,et al.Significance of combined detection of serum pepsinogen,gastrin and Heplicobacter pylori stool antigen inthe diagnosis of atrophic gastritis and gastric cancer[J].Journal of Southeast University(Medical Science Edition),2018,37(3):406-410. [4] JEONG M,PARK J M,HAN Y M,et al.Dietary intervention of artemisia andgreen tea extracts to rejuvenate Helicobacter pylori-associated chronic atrophic gastritis and to prevent tumorigenesis[J].Helicobacter,2016,21(1):40-59. [5] CALIK Z,KARAMESE M,ACAR O,et al.Investigation of helicobacter pylori antigen in stool samples of patients with upper gastrointestinal complaints[J].Braz J Microbiol,2016,47(1):167-171. [6] MUHSEN K,SINNREICH R,BEER-DAVIDSON G,et al.Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody,serum pepsinogens and haemoglobin levels in adults[J].Sci Rep,2018,8(1):17616. [7] 方小鹤,赵平,王江滨.血清胃泌素17在慢性萎缩性胃炎患者中的表达水平及意义[J].中国老年学杂志,2015,35(5):1290-1291. FANG Xiaohe,ZHAO Ping,WANG Jiangbin.Expression levels and significance of serum gastrin 17 in patients with chronic atrophic gastritis[J].Chinese Joutnal of Gerontology,2015,35(5):1290-1291. [8] ZAGARI R M,RABITTI S,GREENWOOD DC,et al.Systematic review with meta-analysis:diagnostic performance of the combination of pepsinogen,gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis[J].Aliment Pharmacol Ther,2017,46(7):657-667. [9] JúNIOR M F,BATISTA S A,BARBUTO R C,et al.CagA-positive Helicobacter pylori strain containing three EPIYA C phosphorylation sites produces increase of G cell and decrease of D cell in experimentally infected gerbils(Merionesunguiculatus)[J].Adv Med Sci,2016,61(2):231-236. [10] 赵缜,潘惠芬,曹国君.胃蛋白酶原检测在非萎缩性胃炎和消化性溃疡患者中的应用[J].国际检验医学杂志,2016,37(9):1245-1247. ZHAO Zhen,PAN Huifen,CAO Guojun.Application of pepsinogen detection inpatients with non atrophic gastritis and peptic Ulcer[J].Int J Lab Med,2016,37(9):1245-1247. [11] OSUMI H,FUJISAKI J,SUGANUMA T,et al.A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication[J].PLoS One,2017,12(8):e0183980. [12] 张培莉,刘义庆,张炳昌,等.体检人群血清胃蛋白酶原,胃泌素-17与幽门螺杆菌抗体分型检测临床分析[J].现代检验医学杂志,2017,32(4):32-35. ZHANG Peili,LIU Yiqing,ZHANG Bingchang,et al.Clinical analysis of serum pepsinogen,gastrin-17 and Helicobacter pylori antibody typing in physical examination[J].J Mod Lab Med,2017,32(4):32-35. [13] KUMAR S,KUMARI N,MITTAL R D,et al.Pepsinogen-II 100 bp ins/del genepolymorphism and its elevated circulating levels are associated with gastric cancer,particularly with Helicobacter pylori infection and intestinal metaplasia[J].Gastric Cancer,2016,19(3):808-816. [14] 曲恒怡,王雪萍,孙华波.幽门螺杆菌感染对胃溃疡患者胃蛋白酶原及胃肠动力状态的影响研究[J].中华医院感染学杂志,2017,27(10):2183-2185,2209. QU Hengyi,WANG Xueping,SUN Huabo.Influence of Helicobacter pylori infection on pepsinogen and gastrointestinal motility state of patients with gastric ulcer[J].Chinese Journal of Nosocomiology,2017,27(10):2183-2185,2209. [15] KOBAYASHI S,OGURA M,SUZAWA N,et al.18F-FDG uptake in the stomach on screening PET/CT:value for predicting Helicobacter pylori infectionand chronic atrophic gastritis[J].BMC Med Imaging,2016,16(1):58. [16] WANG D Q,DING X P,YIN S,et al.Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer[J].Genet Mol Res,2016,15(2):gmr 15027358. [17] 董兵轮,杜明.养胃配方颗粒组方对慢性萎缩性胃炎患者血清炎症指标及中医症状积分影响[J].辽宁中医药大学学报,2017,19(5):183-185. Dong Binglun,DU Ming.Effect of yangwei granule prescription on chronic atrophic gastritis serum inflammation indexes and TCM symptom score[J].Journalof Liaoning University of TCM,2017,19(5):183-185. [18] 王建军,王泽友,姚永良,等.幽门螺杆菌作用巨噬细胞后诱导的炎症反应研究[J].中国免疫学杂志,2015,31(6):737-740. WANG Jianjun,WANG Zeyou,YAO Yongliang,et al.Research on inflammatory respone of Helicobacter pylori treated macrophages[J].Chinese Journal of Immunology,2015,31(6):737-740. [19] HU Zhekai,ZHANG Yu,LI Zhiyu,et al.Effect of Helicobacter pyloriinfection on chronic periodontitis by the change of microecology and inflammation[J].Oncotarget,2016,7(41):66700-66712.

相似文献/References:

[1]史秋霞,李 瑞,邸亚星.慢性萎缩性胃炎患者血清LTB4 和CX3CL1 表达水平及其诊断价值研究[J].现代检验医学杂志,2023,38(03):149.[doi:10.3969/j.issn.1671-7414.2023.03.027]
　SHI Qiu-xia,LI Rui,DI Ya-xing.Serum LTB4 and CX3CL1 Expression Levels and Their Diagnostic Value in Patients with Chronic Atrophic Gastritis[J].Journal of Modern Laboratory Medicine,2023,38(05):149.[doi:10.3969/j.issn.1671-7414.2023.03.027]
[2]张鹏飞,杨小飞,许怀利,等.慢性萎缩性胃炎患者血清ADAM17和CXCL16表达水平与临床价值研究[J].现代检验医学杂志,2024,39(01):73.[doi:10.3969/j.issn.1671-7414.2024.01.013]
　ZHANG Pengfei,YANG Xiaofei,XU Huaili,et al.Study on the Expression and Clinical Value of Serum ADAM17 and CXCL16 Levels in Patients with Chronic Atrophic Gastritis[J].Journal of Modern Laboratory Medicine,2024,39(05):73.[doi:10.3969/j.issn.1671-7414.2024.01.013]

备注/Memo

备注/Memo:
作者简介:肖蓉蓉(1983-),女,本科学历,技师,研究方向:检验微生物,E-mail:1811043279@qq.com。 通讯作者:孙建斌,男,硕士,教授,主任技师,硕士导师,主要从事临床微生物检验,细菌耐药基因同源性研究,E-mail:sjb3h@sina.com。
更新日期/Last Update: 2019-10-20